AcMh-R3

4 trials

Sponsors

Center of Molecular Immunology(CIM), Center of Molecular Immunology (CIM)

Conditions

Advanced epithelial head and neck tumors.Highly malignant astrocytic tumors.Intrinsic diffuse astrocytomas of brain stem.Non-small cells lung cancer with brain metastasis

Phase 2

Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors.

Active, not recruitingRPCEC00000071

Center of Molecular Immunology (CIM)Advanced epithelial head and neck tumors.

Start: 1999-08-09Target: 12Updated: 2026-09-14

h-R3 MaB and radiotherapy in pediatric patients with intrinsic diffuse astrocytomas of brain stem, phase II.

RecruitingRPCEC00000011

Center of Molecular Immunology(CIM)Intrinsic diffuse astrocytomas of brain stem.

Start: 2007-11-21Target: 40Updated: 2026-09-14

Patients with non small cells lung cancer (NSCLC) and brain metastasis.

Active, not recruitingRPCEC00000016

Center of Molecular Immunology (CIM)Non-small cells lung cancer with brain metastasis

Start: 2006-09-08Target: 30Updated: 2026-09-14

Phase 3

hR3 MaB and radiotherapy in highly malignant astrocytic tumors, phase III.

Active, not recruitingRPCEC00000012

Center of Molecular Immunology(CIM)Highly malignant astrocytic tumors.

Start: 2005-02-28Target: 80Updated: 2026-09-14